Elementis/£ELM
1D1W1MYTD1Y5YMAX
Capital at risk
About Elementis
Elementis PLC, designated by the ticker ELM, is a global company specializing in the manufacture and sale of specialty chemicals. Established in 1844, the company primarily operates within the specialty chemicals industry, providing high-performance additives designed to enhance the capability of products across a diverse range of industries including personal care, coatings, talc, and chromium. Elementis is committed to delivering products that respond to the unmet needs and demands of their global clientele, focusing on quality, innovation, and sustainability.
- Ticker
- £ELM
- Sector
- Materials
- Primary listing
- LSE
- Employees
- 989
- Headquarters
- London, United Kingdom
- Website
- www.elementis.com
Elementis Metrics
BasicAdvanced
£1B
18.35
£0.10
0.92
£0.03
1.89%
Price and volume
Market cap
£1B
Beta
0.92
52-week high
£1.95
52-week low
£1.36
Average daily volume
1.4M
Dividend rate
£0.03
Financial strength
Current ratio
2.274
Quick ratio
1.375
Long term debt to equity
0.318
Total debt to equity
0.399
Dividend payout ratio (TTM)
33.47%
Interest coverage (TTM)
8.49%
Profitability
EBITDA (TTM)
120.764
Gross margin (TTM)
48.30%
Net profit margin (TTM)
11.86%
Operating margin (TTM)
22.15%
Effective tax rate (TTM)
30.12%
Revenue per employee (TTM)
£475,800
Management effectiveness
Return on assets (TTM)
7.66%
Return on equity (TTM)
10.67%
Valuation
Price to earnings (TTM)
18.353
Price to revenue (TTM)
2.136
Price to book
1.52
Price to tangible book (TTM)
13.62
Price to free cash flow (TTM)
36.571
Free cash flow yield (TTM)
2.73%
Free cash flow per share (TTM)
0.048
Dividend yield (TTM)
1.89%
Growth
Revenue change (TTM)
7.65%
Earnings per share change (TTM)
-198.87%
3-year revenue growth (CAGR)
-4.29%
10-year revenue growth (CAGR)
-0.41%
3-year earnings per share growth (CAGR)
18.61%
10-year earnings per share growth (CAGR)
-2.94%
10-year dividend per share growth (CAGR)
-6.11%
What the Analysts think about Elementis
Analyst ratings (Buy, Hold, Sell) for Elementis stock.
Analyst projections of the future price of Elementis stock.
Bulls say / Bears say
Elementis delivered 4.7% organic constant-currency revenue growth in the first half, while adjusted operating profit rose 16.4% and margin reached 23%. Coatings was particularly strong, with 5.6% organic growth, showing that the self-help plan is translating into operating leverage. (National Storage Mechanism, Sharecast)
The sale of the pharma business leaves Elementis focused on higher-margin Personal Care and Coatings, with lower future capital intensity. Returning about $35m of proceeds through a buyback also gives shareholders a direct capital-return catalyst. (Elementis, Investegate)
Alchemy Ingredients and new personal-care technologies broaden Elementis’s natural and sustainable beauty offering. If these products scale through the company’s global sales network, they could support growth in a premium, high-margin market rather than relying only on volume recovery. (Elementis, Personal Care Insights)
North American demand remains weak, and management expects the normal seasonal weighting to moderate margins in the second half. That makes the full-year target dependent on continued strength in Asia, Europe and energy applications. (MarketBeat, National Storage Mechanism)
Elementis remains exposed to geopolitical disruption, input-cost inflation and supply-chain problems, including risks linked to the Middle East crisis. Its ability to pass through higher costs has held up so far, but weaker demand could make future price increases harder to achieve. (National Storage Mechanism, Investegate)
Cash conversion needs watching: first-half operating cash flow fell to $29.8m from $41.3m as working capital, tax and capital spending absorbed more cash. If this persists, it could constrain deleveraging and reduce the value of the buyback and dividend story. (MarketBeat)
Data summarised monthly by Lightyear AI. Last updated on 22 Sept 2026.
Elementis Financial Performance
Revenues and expenses
Elementis Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Elementis
AllGBPEURUSD
Fund name | Fund size | £ELM weighting |
|---|---|---|
iShares FTSE 250£MIDD | £661M | 0.33% |
Vanguard FTSE 250£VMID | £1.6B | 0.30% |
Xtrackers MSCI Europe Small Cap€DX2J | €3.2B | 0.09% |
Xtrackers MSCI Europe Small Cap£XXSC | £2.8B | 0.09% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.